240 results on '"tissue factor"'
Search Results
2. Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative Colitis
3. E-Cigarettes induce expression of procoagulant tissue factor in cultivated human endothelial cells
4. Mutational analysis of pig tissue factor pathway inhibitor α to increase anti-coagulation activity in pig-to-human xenotransplantation
5. Tissue factor regulates autophagy in pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension rats via the p38 MAPK-FoxO1 pathway
6. Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock
7. The fluorochrome-to-protein ratio is crucial for the flow cytometric detection of tissue factor on extracellular vesicles
8. Impact of tissue factor expression and administration routes on thrombosis development induced by mesenchymal stem/stromal cell infusions: re-evaluating the dogma
9. Regulation of tissue factor activity by interaction with the first PDZ domain of MAGI1
10. Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shock
11. Conversion of anti-tissue factor antibody sequences to chimeric antigen receptor and bi-specific T-cell engager format
12. Crosstalk of human coronary perivascular adipose-derived stem cells with vascular cells: role of tissue factor
13. EML4-ALK fusion protein in Lung cancer cells enhances venous thrombogenicity through the pERK1/2-AP-1-tissue factor axis
14. A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis
15. Cancer-associated thrombosis and bleeding
16. NLRP3 Inflammasome Overactivation in Patients with Aneurysmal Subarachnoid Hemorrhage
17. Tissue factor: a neglected role in cancer biology
18. A novel prothrombotic role of proprotein convertase subtilisin kexin 9: the generation of procoagulant extracellular vesicles by human mononuclear cells
19. Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes
20. Study on the Effect and Mechanism of miR-185 on Lower Extremity Deep Venous Thrombosis
21. NETosis and SARS-COV-2 infection related thrombosis: a narrative review
22. Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes
23. Detailed exploration of pathophysiology involving inflammatory status and bleeding symptoms between lipopolysaccharide- and tissue factor-induced disseminated intravascular coagulation in rats
24. Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms
25. Tissue factor–bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study
26. A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment
27. Expression of tissue factor mRNA in thrombosis associated with antiphospholipid syndrome
28. Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19
29. Silencing of tissue factor by antisense deoxyoligonucleotide mitigates thioacetamide-induced liver injury
30. Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival
31. AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis
32. LPS-induced expression and release of monocyte tissue factor in patients with haemophilia
33. Accumulation of tissue factor in endothelial cells promotes cellular apoptosis through over-activation of Src1 and involves β1-integrin signalling
34. Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α
35. Expression of tissue factor and tissue factor pathway inhibitors during ovulation in rats: a relevance to the ovarian hyperstimulation syndrome
36. A pilot study evaluating the Calibrated Automated Thrombogram assay and application of plasma-thromboelastography for detection of hemostatic aberrations in horses with gastrointestinal disease
37. Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases
38. Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy
39. Coagulation Activity of Membrane Microparticles
40. Coagulation Properties of Erythrocyte Derived Membrane Microparticles
41. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation
42. Role of Immune Distribution of Tissue Factor in the Development of Hemostasis during the First Trimester of Normal Pregnancy
43. Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis
44. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells
45. Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor
46. Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial
47. Beyond thrombosis: the impact of tissue factor signaling in cancer
48. Characterization of the inhibition mechanism of a tissuefactor inhibiting single-chain variable fragment: a combined computational approach
49. Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
50. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.